Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(79 sites)
United States
The Kirklin Clinic of UAB Hospital, Birmingham, Alabama The University of Alabama at Birmingham, Birmingham, Alabama University of Alabama at Birmingham - Phase I Clinical Trials Unit, Birmingham, Alabama Highlands Oncology Group, PA, Fayetteville, Arkansas Highlands Oncology Group, PA, Rogers, Arkansas